Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Catalent Inc.

www.catalent.com

Latest From Catalent Inc.

Cell And Gene Therapy Manufacturing: Catalent Snaps Up MaSTherCell

Consolidation and acquisitions among contract manufacturers of cell and gene therapies is a growing trend, as Catalent acquires Belgium- and US-based MaSTherCell Global for $315m, and other cell and gene therapy manufacturers address capacity shortages.

 

M & A Regenerative Medicine

Who’s Hired? Sandoz Germany Seeks A New Country Head

While Sandoz looks for a new country head in Germany, Lupin has appointed a new chief corporate development officer and a Coherus executive has left the firm.

Appointments Strategy

AbbVie And Allergan: Five Big Review Questions To Worry About

Mega-merger's top US drug candidates are seeking space in crowded fields. That means they have to get through the FDA fast, and priority review vouchers figure prominently in both improving and lowering the odds.

Drug Review M & A

Manufacturing Round-Up: FDA Demands Meeting With Aurobindo Over Issues At Multiple Sites

An FDA warning letter issued to Aurobindo highlights recurring failures over several sites, while Teva is setting up a biologics development campus in the US and Nexus is investing in sterile injectables capacity.

Manufacturing Compliance
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
    • Gene Therapy, Cell Therapy
    • Large Molecule
    • Synthesis Technologies, Production Processes
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Macromolecule
    • OTC, Consumer
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Cardinal Health PTS
  • Catalent Inc.
  • Catalent Pharma Solutions Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Catalent Inc.
  • Senior Management
  • John Chiminski, Chmn. & CEO
    Wetteny Joseph, SVP, CFO
    Scott Gunther, SVP, Quality & Reg. Affairs
    Alessandro Maselli, Pres. & COO
    Karen Flynn, Chief Commercial Officer
  • Contact Info
  • Catalent Inc.
    Phone: (732) 537-6200
    14 Schoolhouse Rd.
    Somerset, NJ 08873
    USA
UsernamePublicRestriction

Register